BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Mammalian target of rapamycin inhibitors
1
Mammalian target of rapamycin; novel insight for management of inflammatory bowel diseases
1/25/2022 7:27:40 AM | Browse: 744 | Download: 1831
2
Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant
4/20/2017 8:08:00 PM | Browse: 1245 | Download: 2442
3
Organ transplantation and drug eluting stents: Perioperative challenges
12/14/2016 2:15:00 PM | Browse: 1035 | Download: 1489
4
Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation
3/18/2016 2:28:00 PM | Browse: 979 | Download: 1808
5
Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients
12/23/2015 8:26:00 AM | Browse: 1275 | Download: 2444
6
Hepatocellular carcinoma: A comprehensive review
11/18/2015 11:12:00 AM | Browse: 1590 | Download: 2266
7
Conversion from calcineurin inhibitors to mTOR inhibitors stabilizes diabetic and hypertensive nephropathy after liver transplant
3/24/2015 5:37:00 PM | Browse: 1173 | Download: 1888
8
Hepatitis B reactivation related to everolimus
9/10/2014 3:18:00 PM | Browse: 1154 | Download: 791
9
“Targeting” renal cell carcinoma patients with “targeted” agents: Are we there yet?
9/3/2014 10:06:00 AM | Browse: 993 | Download: 1185